About 50% of gliomas do not express p16/CDKN2 protein or mRNA.98 When the wild-type p16/CDKN2 gene is present, it is transcriptionally repressed by aberrant hypermethylation of the CpG island. Here, CDKN2A is linked to central nervous system cancer.